Expert insights on ketamine therapy, mental health treatment, and evidence-based care from Dr. Ben Soffer and the Tovani Health team.
Patients searching ketamine at home mean different things, and the route of administration changes everything about what a legitimate physician-led practice can actually offer. Here is an honest, route-by-route breakdown from a board-certified physician.
What does it take to become a certified Ketamine Assisted Psychotherapy therapist? Here's a practical overview of training pathways, certification requirements, and the competencies that matter most.
The FDA investigated whether GLP-1 drugs increase suicide risk — and on January 13, 2026 formally requested removal of the warning from the three weight-loss labels (Saxenda, Wegovy, Zepbound) that ever carried it. Here's what patients on Ozempic, Wegovy, Mounjaro, and similar drugs actually need to know about mood, depression, and suicidality.
Patients searching ketamine at home mean different things, and the route of administration changes everything about what a legitimate physician-led practice can actually offer. Here is an honest, route-by-route breakdown from a board-certified physician.
Ketamine-assisted psychotherapy raises unique ethical questions about consent during altered states, professional boundaries, and patient vulnerability. A practical framework for clinicians.
Comprehensive guide for licensed psychologists facilitating group Ketamine Assisted Psychotherapy sessions, including group dynamics, safety protocols, and therapeutic techniques.
Comprehensive clinical reference on ketamine drug interactions for prescribers: covering SSRIs, SNRIs, MAOIs, triptans, opioids, benzodiazepines, lamotrigine, lithium, and the actual (versus presumed) risk of serotonin syndrome.
Comprehensive guide to integration therapy approaches for licensed therapists working with patients following ketamine-assisted psychotherapy sessions.
Advanced trauma-informed approaches for licensed therapists conducting Ketamine Assisted Psychotherapy with PTSD and complex trauma patients.
GLP-1 agonists like Ozempic, Wegovy, and Mounjaro don't directly interact with ketamine, but they share overlapping side effects and one practical issue that matters on session day.
Detailed guide to therapeutic interventions and techniques for licensed therapists providing support during ketamine-assisted psychotherapy sessions.
What does it take to become a certified Ketamine Assisted Psychotherapy therapist? Here's a practical overview of training pathways, certification requirements, and the competencies that matter most.
Comprehensive emergency response protocols and crisis management procedures for clinicians administering ketamine therapy.
Detailed psychiatric evaluation frameworks and consultation protocols for clinicians assessing ketamine therapy candidates.
Comprehensive guide to implementing ketamine therapy services, including practice management, billing considerations, and economic sustainability.
A physician's honest comparison of at-home and clinic-based ketamine therapy: the real safety differences, the cost math, and how to figure out which one actually fits your life.
Comprehensive medical guide to ketamine therapy for treatment-resistant depression, anxiety, and chronic pain. Professional-grade information for clinicians and discerning patients.
Essential training requirements, certification pathways, and competency standards for clinicians offering ketamine therapy services.
Comprehensive review of ketamine pharmacology, mechanisms of action, and clinical implications for healthcare professionals prescribing ketamine therapy.
A critical review of the clinical evidence supporting ketamine therapy for treatment-resistant depression, anxiety, and PTSD. Response rates, durability of effect, and what the data means for referring physicians.
Comprehensive clinical protocols for healthcare professionals administering ketamine therapy for treatment-resistant depression and anxiety disorders.
Clinical comparison of ketamine and SSRI mechanisms of action, efficacy data, and prescribing considerations for medical professionals.
What separates a real at-home ketamine program from a fly-by-night one: physician monitoring intervals, support-person rules, blood-pressure cutoffs, and when to escalate.
Comprehensive training requirements and certification pathways for healthcare professionals implementing ketamine therapy programs.
An honest look at how we screen, prepare, and supervise patients through at-home ketamine therapy, written by Dr. Ben Soffer.
Dr. Ben Soffer on what treatment-resistant depression actually means, why ketamine works when SSRIs haven't, and what he tells patients before they decide.
Comprehensive medical supervision standards and safety protocols for clinicians administering ketamine therapy in clinical settings.
Evidence-based referral criteria and clinical considerations for primary care physicians referring patients for ketamine therapy treatment.
Comparing at-home sublingual ketamine to in-clinic IV infusions on effectiveness, safety, cost, and convenience. A physician's honest look at what the evidence says and how to choose the right option for you.
Patients ask about microdosing ketamine regularly. Dr. Ben Soffer on why the clinical evidence supports full therapeutic doses, what's actually known about sub-perceptual dosing, and what the question is usually really about.
Healthcare workers face a burnout epidemic fueled by compassion fatigue and moral injury. Dr. Ben Soffer on why at-home ketamine addresses the specific barriers this profession faces: confidentiality, scheduling, and the culture of pushing through.
Dr. Ben Soffer on why journaling during ketamine therapy improves outcomes: what to write before, during, and after sessions, plus a practical mood- tracking approach that shows progress you can't see subjectively.
About 30% of treatment-resistant depression patients don't respond to ketamine therapy. Dr. Ben Soffer on how to tell the difference between non-response and partial response, what adjustments to try, and what alternatives exist.
Proper nutrition and timing around ketamine sessions can significantly reduce nausea and improve your experience. Learn what to eat, when to eat, and what to avoid before and after treatment.
Ketamine therapy can be safe and effective for older adults, but it requires careful consideration of blood pressure, fall risk, medication interactions, and other age-specific factors. This guide covers what seniors and their families need to know.
If you've tried two or more antidepressants without finding adequate relief, you're in a category called treatment-resistant depression. Dr. Ben Soffer walks through what that means and the evidence-based options worth considering.
Ketamine has shown rapid anti-suicidal effects in research, often within hours. Dr. Ben Soffer on what that evidence actually supports, what ketamine is not, and when to call 988.
A physician's frank perspective on THC, CBD, and ketamine therapy: what we know, what we don't, and why pausing cannabis during the initial treatment course usually produces better results.
A physician's walkthrough of the real differences between ketamine therapy and TMS: speed, what each session asks of you, what the research actually shows, and when to combine them.
First responders carry a distinct form of PTSD from cumulative occupational trauma. Dr. Ben Soffer on why standard treatments often fall short, why the at-home model addresses the confidentiality problem, and what the treatment actually looks like.
A physician's practical guide to having this conversation: what to say, how to frame it, and what to do if your clinician is skeptical or opposed.
A physician's straight answer on driving and activity restrictions after at-home ketamine therapy: why you wait until the next day, what else to avoid, and how to plan your treatment day.
A physician's walkthrough of when Spravato makes sense, when at-home ketamine makes sense, and the questions I actually ask patients to figure out which one fits.
Dr. Ben Soffer on why traditional antidepressants often fall short for depression emerging during perimenopause and menopause, and why ketamine's different mechanism may be better suited to the underlying biology.
Ketamine therapy is contraindicated during pregnancy and breastfeeding. Learn why, when to stop treatment before conceiving, and what alternatives exist for managing postpartum depression safely.
A physician's honest look at ketamine therapy for social anxiety disorder: why SSRIs often underperform, how ketamine's different mechanism targets the avoidance circuitry, and what integration work actually matters.
Ketamine therapy is legal in New Jersey when prescribed by a licensed clinician. Dr. Ben Soffer walks through the state telehealth rules, the Ryan Haight Act, and how to identify a legitimate practice.
A physician's letter to the support person: what your role actually is, what to do, what not to do, and what to watch for during at-home ketamine sessions.
A physician's walkthrough of at-home ketamine therapy for New Jersey residents, from eligibility screening through pharmacy delivery to ongoing monitoring, and the NJ-specific telehealth framework that makes it possible.
Ketamine therapy costs vary dramatically depending on the setting. Compare at-home ketamine pricing starting at $249/month with in-clinic sessions that can run $400-800 each, and learn how to use HSA/FSA funds for treatment.
A physician's realistic timeline for what to expect during ketamine therapy: from the first session through the loading phase to maintenance, and why the speed compared to SSRIs is one of its most useful features.
Chronic pain and depression share brain circuitry. Dr. Ben Soffer on how ketamine's NMDA receptor modulation addresses both, which pain conditions tend to respond, and where ketamine isn't the right tool.
Yes, at-home ketamine therapy is legal in Florida when prescribed by a licensed physician. Dr. Ben Soffer explains the regulatory landscape, what makes a practice legitimate, and the red flags to watch for.
A physician's honest comparison of Wellbutrin (bupropion) and ketamine therapy: what each one targets, when to switch, and why combining them is often the right answer.
Benzodiazepines like Xanax, Klonopin, and Ativan can reduce ketamine's therapeutic effect. Dr. Ben Soffer on the real interaction, when a taper makes sense, and when it doesn't.
Yes, most patients on Lexapro can safely add ketamine therapy. Dr. Ben Soffer explains the actual interaction risk, dosing protocol, and the rare cases that need a taper.
Mixing ketamine with alcohol poses real safety risks and undermines treatment outcomes. Dr. Ben Soffer on the actual interaction, how long to abstain, and the depression-alcohol cycle.
Sleep problems and depression feed each other. Dr. Ben Soffer on how ketamine's different mechanism can address both, and why sleep improvement is often one of the first signs a patient is responding.
A physician's perspective on Zoloft (sertraline), why it stops working for some patients, when ketamine is a better fit, and how to think about the transition.
Dr. Ben Soffer on ketamine therapy safety: what the side effect profile actually looks like at therapeutic dose, the serious risks worth knowing about, and who shouldn't take it.
Ketamine therapy is FSA/HSA-eligible with a physician's letter of medical necessity. Save roughly 30% pre-tax, about $105 off a $349 month. Here's exactly how to file the claim.
Wondering what happens during a ketamine therapy consultation? Walk through every step of Tovani Health's telehealth evaluation process, from medical history review to personalized treatment planning.
Curious about the ketamine therapy experience? Learn what patients actually feel during treatment, from the calming float to emotional breakthroughs, and how to prepare for your first session.
Beyond the blog: free interactive tools and plain-English clinical guides to 60 conditions, the major therapies, and how treatment actually works. Educational, not a diagnosis.
A private, evidence-based self-assessment that points to areas worth discussing — with a PDF summary you can email yourself.
Start the check-inAnswer a few questions to surface the depression, anxiety, and treatment-resistant options most worth raising with a prescriber.
Explore options